Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use

Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here’s what investors need to know. • TLRY is among today’s top performers. Stay ahead of the curve here.What To Know: A study in the American Journal of Health Economics found medical cannabis legalization is "associated with significant reductions in opioid prescribing.”Analyzing ...